Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia
Public ClinicalTrials.gov record NCT04871451. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Repeat Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Open-label Extension trial will evaluate the safety and efficacy of ABP-450 for the treatment of cervical dystonia in adults. The study will enroll 60 patients across approximately 42 sites in the United States from Phase 2 (ABP-19000) trial. Study subjects who had their initial dose of study drug in the Phase 2 trial, irrespective of treatment allocation, will be eligible to enroll in this OLE study.
Study identification
- NCT ID
- NCT04871451
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2021 (Actual)
- Primary completion
- Jul 24, 2023 (Actual)
- Completion
- Jul 24, 2023 (Actual)
- Last update posted
- Aug 22, 2024
2021 – 2023
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Neuroscience Research | Phoenix | Arizona | 85032 | — |
| Parkinson's and Movement Disorder Institute | Fountain Valley | California | 92708 | — |
| Neuro Pain Medical Center | Fresno | California | 93710 | — |
| Loma Linda University | Loma Linda | California | 92354 | — |
| New England Institute for Neurology and Headache | Stamford | Connecticut | 06905 | — |
| Infinity Clinical Research LLC | Hollywood | Florida | 33024 | — |
| Brainstorm Research | Miami | Florida | 33176 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| Neurology One | Winter Park | Florida | 32792 | — |
| Emory University | Atlanta | Georgia | 30329 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Michigan State University | East Lansing | Michigan | 48824 | — |
| Quest Research Institute - Hunt - PPDS | Farmington Hills | Michigan | 48334 | — |
| University of New Mexico | Albuquerque | New Mexico | 87106 | — |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Cleveland Clinic Lou Ruvo Center for Brain Health | Cleveland | Ohio | 89106 | — |
| The Orthopedic Foundation | New Albany | Ohio | 43054 | — |
| Veracity Neuroscience LLC | Memphis | Tennessee | 38157 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04871451, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 22, 2024 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04871451 live on ClinicalTrials.gov.